GBA1 and Parkinson disease: Similarly, Kim et al. (2018) demonstrated that pharmacological inhibition of ASAH1 led to a significant reduction in GBA1-linked cellular phenotypes, including accumulation of ubiquitinated proteins and α-synuclein in dopaminergic neuronal cultures derived from PD GBA1+/− patients.